Publications by authors named "Al Enriquez"

Claim this Profile
E
Elevated SARS-CoV-2 IgG4 in plasma and mucosa following repeated mRNA boosters impact antibody functions to Omicron and sarbecoviruses.
Kevin J Selva, Wen Shi Lee, Alther L Enriquez, L Carissa Aurelia, Jennifer Audsley

EBioMedicine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multimedia program for caregivers of pediatric patients with chronic kidney disease in Guatemala.
Brooke M Ramay, Ana Gabriela Espinoza Sierra, Ana Lucía Enríquez, Celeste Espel, Cristina Zelaya

J Pediatr Nurs· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of overactive bladder with botulinum toxin type B: a pilot study.
Dennis Dykstra, Al Enriquez, Michael Valley

Int Urogynecol J Pelvic Floor Dysfunct· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype.
Shoichiro Nakao, Chihaya Kodama, Toshihiro Takenaka, Akihiro Tanaka, Yuichiro Yasumoto, Annette L D Enriquez

Kidney Int· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fabry disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes.
C M Eng, G A Ashley, T S Burgert, A L Enriquez, M D'Souza

Mol Med· March 1997

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fabry disease: twenty-three mutations including sense and antisense CpG alterations and identification of a deletional hot-spot in the alpha-galactosidase A gene.
C M Eng, D J Niehaus, A L Enriquez, T S Burgert, M D Ludman

Hum Mol Genet· October 1994

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis